ESUN

Contributions to ESUN by Members of the CTOS Board of Directors

By Bruce Shriver, PhD
Editor-in-Chief, ESUN

While recently working on an electronic book project, I reviewed an extensive amount of material that we have published in ESUN over the past seven and a half years. During one period, we published a series of opinion pieces (OpEds) by various members of the Board of Directors of the Connective Tissue Oncology Society (CTOS). Because I found many of them extremely interesting and still quite relevant, I thought it would be useful to bring them all together in one place, with their links, to make it easy for you to access them.

• Controversies in Sarcoma by German Marulanda MD and G. Douglas Letson MD
• Community Physicians - Should They Refer that Lump or Bump Before Intervention? Yes, This is Why We Have Multidisciplinary Sarcoma Centers! by Prof. Ian Judson MD, FRCP
• The Difficulty and Promise of Immunotherapy for Sarcomas by Robert Maki, MD, PhD
• Of Mice and Men: Why We Need to Embrace Mouse Models of Human Sarcomas by Brian Rubin, MD, PhD
• The Margin Matters: Someone's Life Depends Upon It by R. Lor Randall, MD, FACS
• NF1 Patients: Risks for Sarcoma and the Expedited Referral of Concerning Cases by David Viskochil, MD, PhD
• PET and Sarcoma by Janet F. Eary, MD and Ernest U. Conrad, MD
• Pediatric Orthopedic Implants by G. Douglas Letson, MD and M. Stephen Wilson, MD
• Cancer Stem Cells in Sarcoma by C. Parker Gibbs, MD
• The Importance of the Molecular Scalpel by R. Lor Randall, MD, FACS
• Extra-Abdominal Primary Fibromatosis: Strategy According to Molecular Findings? by Sylvie Bonvalot, MD, PhD
• Aggressive Fibromatosis: A Problem for the Sarcoma Team by Randall Burt, MD and David Viskochil, MD, PhD
• Management in Low-Grade Chondrosarcoma by Eduardo Novais, MD and R. Lor Randall, MD, FACS
• Understanding Rare Cancers: The NIH Pediatric and wildtype GIST Clinic Paradigm by Su Young Kim, MD, PhD  and Lee J. Helman, MD
• Sarcoma Alliance for Research through Collaboration (SARC): An effort to perform clinical trials more efficiently and effectively for people with sarcoma Robert Maki, MD, PhD
• The Creation of a Robust Registry of Sarcoma Patients and Biological Resources by Paul A. Meyers, MD

I hope you find some of them interesting and useful. If so, you may want to bookmark this page. I welcome any comments regarding these OpEd pieces.